Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

NUB1/NYREN18 Antibody (OTI2G1), DyLight 680, Novus Biologicals™
SDP

Catalog No. NBP273082FR Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP273082FR 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP273082FR Supplier Novus Biologicals Supplier No. NBP273082FR
Add to Cart
Add to Cart

Mouse Monoclonal Antibody

NUB1/NYREN18 Monoclonal specifically detects NUB1/NYREN18 in Human, Mouse, Rat, Canine samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry.

Specifications

Antigen NUB1/NYREN18
Applications Western Blot, Flow Cytometry, Immunohistochemistry
Classification Monoclonal
Clone OTI2G1
Conjugate DyLight 680
Dilution Western Blot, Flow Cytometry, Immunohistochemistry
Formulation PBS with 0.05% Sodium Azide
Gene Alias BS4, NEDD8 ultimate buster-1, negative regulator of ubiquitin-like proteins 1NUB1L, NY-REN-18 antigen, NYREN18NEDD8 ultimate buster 1, Renal carcinoma antigen NY-REN-18
Gene Symbols NUB1
Host Species Mouse
Immunogen Recombinant protein fragment corresponding to amino acids 1-326 of human NUB1/NYREN18 (NP_057202) produced in E.coli.
Purification Method Affinity Purified
Quantity 0.1 mL
Primary or Secondary Primary
Gene ID (Entrez) 51667.0
Target Species Human, Mouse, Rat, Canine
Content And Storage Store at 4°C in the dark.
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.